Invesco’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-41,029
| Closed | -$128K | – | 4183 |
|
|
2021
Q4 | $128K | Sell |
41,029
-3,481
| -8% | -$11.7K | ﹤0.01% | 3869 |
|
|
2021
Q3 | $160K | Buy |
44,510
+7,209
| +19% | +$27.2K | ﹤0.01% | 3860 |
|
|
2021
Q2 | $134K | Buy |
37,301
+13,572
| +57% | +$47.9K | ﹤0.01% | 3855 |
|
|
2021
Q1 | $93K | Buy |
23,729
+4,561
| +24% | +$18.8K | ﹤0.01% | 3767 |
|
|
2020
Q4 | $81K | Buy |
+19,168
| New | +$73.9K | ﹤0.01% | 3672 |
|
|
2020
Q1 | – | Sell |
-385,670
| Closed | -$2.44M | – | 3828 |
|
|
2019
Q4 | $2.44M | Buy |
+385,670
| New | +$2.27M | ﹤0.01% | 2558 |
|
|
2019
Q2 | – | Sell |
-185,398
| Closed | -$983K | – | 3857 |
|
|
2019
Q1 | $983K | Buy |
+185,398
| New | +$847K | ﹤0.01% | 3026 |
|
|
2015
Q3 | – | Sell |
-630
| Closed | -$5K | – | 4301 |
|
|
2015
Q2 | $5K | Sell |
630
-4,195,081
| -100% | -$36M | ﹤0.01% | 4269 |
|
|
2015
Q1 | $44.1M | Buy |
4,195,711
+1,134,280
| +37% | +$15.5M | 0.02% | 856 |
|
|
2014
Q4 | $36.8M | Buy |
3,061,431
+496,104
| +19% | +$7.54M | 0.01% | 943 |
|
|
2014
Q3 | $43.8M | Buy |
2,565,327
+2,411,675
| +1,570% | +$35M | 0.02% | 852 |
|
|
2014
Q2 | $1.85M | Buy |
+153,652
| New | +$1.46M | ﹤0.01% | 2632 |
|
|
2014
Q1 | – | Sell |
-101,810
| Closed | -$600K | – | 4470 |
|
|
2013
Q4 | $600K | Buy |
101,810
+2,065
| +2% | +$10.6K | ﹤0.01% | 3371 |
|
|
2013
Q3 | $542K | Sell |
99,745
-113,042
| -53% | -$543K | ﹤0.01% | 3368 |
|
|
2013
Q2 | $864K | Buy |
+212,787
| New | +$999K | ﹤0.01% | 2974 |
|
Other funds holding BDSI
Invesco's BDSI Position: Q1 2022 in Review
Invesco sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 41,029 shares — an estimated $128K sold.
Invesco first reported a position in BDSI in Q2 2013 and held it in 15 quarters. The position peaked at $44.1M in Q1 2015. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Invesco reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Invesco sold 41,029 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $128K.
- Invesco first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 15 quarters.
- Invesco's BioDelivery Sciences International, Inc. position peaked at $44.1M in Q1 2015.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Invesco's 13F filing for Q1 2022, filed 16 May 2022.